United States: Teva Files Certiorari Petition In "Skinny" Label Case - Oblon, McClelland, Maier & Neustadt, L.L.P

On July 11, Teva filed its petition for certiorari from the Federal Circuit's second decision in its "skinny label" litigation with GSK, 7 F.4th 1320 (Fed, Cir. 2022).